These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3699091

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E, Friedman E.
    Eur J Pharmacol; 1981 Nov 19; 76(1):25-9. PubMed ID: 7318921
    [Abstract] [Full Text] [Related]

  • 25. Behavioral sensitization following a single apomorphine pretreatment--selective effects on the dopamine release process.
    Wilcox RE, Severson JA, Woodward JJ, Randall PK, Vaughn DM, Riffee WH.
    Brain Res; 1990 Sep 24; 528(1):109-13. PubMed ID: 2147118
    [Abstract] [Full Text] [Related]

  • 26. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S, Glowinski J, Hamon M.
    J Neurochem; 1986 Jan 24; 46(1):12-22. PubMed ID: 2866232
    [Abstract] [Full Text] [Related]

  • 27. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T, Sharp T, Ungerstedt U.
    Eur J Pharmacol; 1984 Oct 30; 106(1):27-37. PubMed ID: 6085051
    [Abstract] [Full Text] [Related]

  • 28. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR.
    Brain Res; 1982 Feb 18; 234(1):123-36. PubMed ID: 7059818
    [Abstract] [Full Text] [Related]

  • 29. Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors.
    Tanganelli S, Fuxe K, von Euler G, Agnati LF, Ferraro L, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep 18; 342(3):300-4. PubMed ID: 2280797
    [Abstract] [Full Text] [Related]

  • 30. Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
    Bowyer JF, Weiner N.
    J Pharmacol Exp Ther; 1987 Apr 18; 241(1):27-33. PubMed ID: 3572788
    [Abstract] [Full Text] [Related]

  • 31. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
    Tissari AH.
    Med Biol; 1982 Feb 18; 60(1):38-41. PubMed ID: 6121960
    [Abstract] [Full Text] [Related]

  • 32. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes.
    Onali P, Olianas MC, Bunse B.
    Brain Res; 1988 Jul 26; 456(2):302-9. PubMed ID: 2905190
    [Abstract] [Full Text] [Related]

  • 33. Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.
    Imazu Y, Kobayashi K, Shohmori T.
    Neurochem Res; 1989 May 26; 14(5):459-64. PubMed ID: 2747836
    [Abstract] [Full Text] [Related]

  • 34. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats].
    Kudrin VS, Hetey L, Morgenshtern R, Raevskiĭ KS, Olssner W.
    Farmakol Toksikol; 1987 May 26; 50(2):16-20. PubMed ID: 2884129
    [Abstract] [Full Text] [Related]

  • 35. Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats.
    Spampinato U, Girault JA, Danguir J, Savaki HE, Glowinski J, Besson MJ.
    Brain Res Bull; 1986 Feb 26; 16(2):161-6. PubMed ID: 3697784
    [Abstract] [Full Text] [Related]

  • 36. In vitro characterisation of dopamine receptors in the superior colliculus of the rat.
    Weller ME, Rose S, Jenner P, Marsden CD.
    Neuropharmacology; 1987 Apr 26; 26(4):347-54. PubMed ID: 2438586
    [Abstract] [Full Text] [Related]

  • 37. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb 26; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 38. The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.
    van Oene JC, de Vries JB, Horn AS.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct 26; 327(4):304-11. PubMed ID: 6514014
    [Abstract] [Full Text] [Related]

  • 39. Apomorphine- and haloperidol-induced change in 3,4-dihydroxyphenylacetic acid content in the mesolimbic-striatum of the developing rat.
    Nomura Y, Oki K, Segawa T.
    J Pharmacobiodyn; 1980 Feb 26; 3(2):111-6. PubMed ID: 7205536
    [Abstract] [Full Text] [Related]

  • 40. The striatonigral fibres and the feedback control of dopamine metabolism.
    Tulloch IF, Arbuthnott GW, Wright AK, Garcia-Munoz M, Nicolaou NM.
    Psychol Med; 1978 Aug 26; 8(3):471-82. PubMed ID: 30106
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.